9.9 Aliskiren, a Novel Renin Inhibitor, is Well Tolerated and Has Sustained BP-Lowering Effects Alone or in Combination with HCTZ During Long-Term (52 Weeks) Treatment of Hypertension

Saved in:
Bibliographic Details
Published in:High blood pressure & cardiovascular prevention 2007-09, Vol.14 (3), p.145-145
Main Authors: Destro, M, Sica, D, Gradman, A, Lederballe, O, Meyers, M, Cai, J, Keefe, D. L, Maiocchi, G
Format: Article
Language:English
Subjects:
Hypertension
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1120-9879
1179-1985
DOI:10.2165/00151642-200714030-00162